New Long-Term Data for Genentech's Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)
– Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision –– Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apart –– Detailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, a...